H.J.Res. 7 · 118th Congress · Emergency Management
Relating to a national emergency declared by the President on March 13, 2020.
- IntroducedJan 9, 2023 Done
- CommitteeWent to the floor without a report Not needed
- House floorPassed 229–197 · Feb 1, 2023 Done
- Senate floorPassed 68–23 · Mar 29, 2023 Done
- Chambers agreeIdentical, not needed Not needed
- PresidentSigned Apr 10, 2023 Done
What it does
This joint resolution terminates the national emergency concerning COVID-19 declared by the President on March 13, 2020.
Congressional Research Service · summary of “Public Law” version · Apr 10, 2023
Votes
-
Senate · On Passage of the Bill Mar 29, 2023 · Roll call 8068–23Passed
-
House · On Passage Feb 1, 2023 · Roll call 104229–197Passed
Top row Yea · bottom row NayD left, R right, independents betweenDemocratsRepublicansIndependents
Who lobbies on it
6 organizations · 6 filings · Q1 2023–Q4 2024These 6 organizations’ PACs gave $106K to 21 of the 69 members sponsoring or cosponsoring H.J.Res. 7 in the 2025–26 election cycle.
One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
American Benefits Council
1 of 8 quarters
“Legislative End of National Emergency (COVID-19) - H.J.Res.7, Public Law No: 118-3 Coverage of recommended preventative services -Affordable Care Acts (ACA) preventative services requirement, Braidwood v. Becerra ruling Pharmacy Benefit Manager (PBM) legislation including the PBM Reform Act - S. 1339 Safe Step Act…”
$1.4M lobbying spend in 2023, all issuesQ2 2023 filing
-
American Medical Association
1 of 8 quarters
“Issues related to cybersecurity in the healthcare sector; H.J.Res.7, terminating the national emergency related to the COVID-19 pandemic; Implementation of the No Surprises Act (P.L. 116-260)”
$20.6M lobbying spend in 2023, all issuesQ1 2023 filing
-
Walgreen Company
1 of 8 quarters
“H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. H.J. Res. 7 - The Covid-19 National Emergency: Issues related to the public health emergency. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023: Issues related to Pharmacy Benefit Manager (PBM)…”
$3.2M lobbying spend in 2023, all issuesQ1 2023 filing
3 more organizations, every filingPROUpgrade
Organizations that named H.J.Res. 7 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
23 actions · newest first- Apr 10, 2023Became Public Law No: 118-3.
- Apr 10, 2023Signed by President.
- Apr 5, 2023Presented to President.
- Mar 30, 2023Message on Senate action sent to the House.
Show all 23 actionsShow fewer
- Mar 29, 2023Passed Senate without amendment by Yea-Nay Vote. 68 - 23. Record Vote Number: 80.
- Mar 29, 2023Passed/agreed to in Senate: Passed Senate without amendment by Yea-Nay Vote. 68 - 23. Record Vote Number: 80.
- Mar 29, 2023Measure laid before Senate by unanimous consent. (consideration: CR S1028, S1043-1044)
- Mar 28, 2023Placed on Senate Legislative Calendar under General Orders. Calendar No. 33.
- Mar 28, 2023Senate Committee on Finance discharged pursuant to 50 U.S.C. 1622.
- Feb 2, 2023Received in the Senate and Read twice and referred to the Committee on Finance.
- Feb 1, 2023Motion to reconsider laid on the table Agreed to without objection.
- Feb 1, 2023On passage Passed by the Yeas and Nays: 229 - 197 (Roll no. 104). (consideration: CR H608)
- Feb 1, 2023Passed/agreed to in House: On passage Passed by the Yeas and Nays: 229 - 197 (Roll no. 104). (consideration: CR H608)
- Feb 1, 2023Considered as unfinished business. (consideration: CR H612-613)
- Feb 1, 2023POSTPONED PROCEEDINGS - At the conclusion of debate on H.J. Res. 7, the Chair put the question on passage and by voice vote, announced that the ayes had prevailed. Mr. Graves (MO) demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
- Feb 1, 2023The previous question was ordered pursuant to the rule.
- Feb 1, 2023DEBATE - The House proceeded with one hour of debate on H.J. Res. 7.
- Feb 1, 2023Rule provides for consideration of H.J. Res. 7, H.R. 139, H.R. 382 and H.R. 497. All bills are considered under a closed rule with one hour of general debate and one motion to recommit.
- Feb 1, 2023Considered under the provisions of rule H. Res. 75. (consideration: CR H607-611)
- Feb 1, 2023Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.
- Jan 31, 2023Rules Committee Resolution H. Res. 75 Reported to House. Rule provides for consideration of H.J. Res. 7, H.R. 139, H.R. 382 and H.R. 497. All bills are considered under a closed rule with one hour of general debate and one motion to recommit.
- Jan 9, 2023Referred to the House Committee on Transportation and Infrastructure.
- Jan 9, 2023Introduced in House